Figure 4.

HZ-related prescriptions avoided with RZV vaccination in a population of 1 million adults aged ≥50 years .
aCalculated based on the size of the population vaccinated with RZV and the NNV to avoid one HZ case from RZV cost-effectiveness model.41
bCalculated based on number of HZ cases prevented and painkiller prescription rates.
HZ: herpes zoster; NNV: number needed to vaccinate; RZV: recombinant zoster vaccine